193 related articles for article (PubMed ID: 25942465)
21. Predictors of lost to follow-up in a "test and treat" programme among adult women with high-risk sexual behavior in Kampala, Uganda.
Kamacooko O; Mayanja Y; Bagiire D; Namale G; Hansen CH; Seeley J
BMC Public Health; 2020 Mar; 20(1):353. PubMed ID: 32183759
[TBL] [Abstract][Full Text] [Related]
22. High attrition among HIV-infected patients with advanced disease treated in an intermediary referral center in Maputo, Mozambique.
Molfino L; Kumar AM; Isaakidis P; Van den Bergh R; Khogali M; Hinderaker SG; Magaia A; Lobo S; Edwards CG; Walter J
Glob Health Action; 2014; 7():23758. PubMed ID: 24717189
[TBL] [Abstract][Full Text] [Related]
23. High attrition before and after ART initiation among youth (15-24 years of age) enrolled in HIV care.
Lamb MR; Fayorsey R; Nuwagaba-Biribonwoha H; Viola V; Mutabazi V; Alwar T; Casalini C; Elul B
AIDS; 2014 Feb; 28(4):559-68. PubMed ID: 24076661
[TBL] [Abstract][Full Text] [Related]
24. HIV programmatic outcomes following implementation of the 'Treat-All' policy in a public sector setting in Eswatini: a prospective cohort study.
Kerschberger B; Schomaker M; Jobanputra K; Kabore SM; Teck R; Mabhena E; Mthethwa-Hleza S; Rusch B; Ciglenecki I; Boulle A
J Int AIDS Soc; 2020 Mar; 23(3):e25458. PubMed ID: 32128964
[TBL] [Abstract][Full Text] [Related]
25. Patient-mix, programmatic characteristics, retention and predictors of attrition among patients starting antiretroviral therapy (ART) before and after the implementation of HIV "Treat All" in Zimbabwe.
Makurumidze R; Buyze J; Decroo T; Lynen L; de Rooij M; Mataranyika T; Sithole N; Takarinda KC; Apollo T; Hakim J; Van Damme W; Rusakaniko S
PLoS One; 2020; 15(10):e0240865. PubMed ID: 33075094
[TBL] [Abstract][Full Text] [Related]
26. Community adherence support improves programme retention in children on antiretroviral treatment: a multicentre cohort study in South Africa.
Grimwood A; Fatti G; Mothibi E; Malahlela M; Shea J; Eley B
J Int AIDS Soc; 2012 May; 15(2):17381. PubMed ID: 22713255
[TBL] [Abstract][Full Text] [Related]
27. Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003-2015).
Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC
BMC Public Health; 2019 Aug; 19(1):1120. PubMed ID: 31416432
[TBL] [Abstract][Full Text] [Related]
28. Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004-2012: a cohort study.
Mberi MN; Kuonza LR; Dube NM; Nattey C; Manda S; Summers R
BMC Health Serv Res; 2015 Jul; 15():259. PubMed ID: 26141729
[TBL] [Abstract][Full Text] [Related]
29. Long-term retention and predictors of attrition for key populations receiving antiretroviral treatment through community-based ART in Benue State Nigeria: A retrospective cohort study.
Ibiloye O; Jwanle P; Masquillier C; Van Belle S; Jaachi E; Amoo O; Isah A; Omole T; Samuel JO; van Olmen J; Lynen L; Okonkwo P; Decroo T
PLoS One; 2021; 16(11):e0260557. PubMed ID: 34847194
[TBL] [Abstract][Full Text] [Related]
30. Effective public-private partnerships for sustainable antiretroviral therapy: outcomes of the Right to Care health services GP down-referral program.
Mokhele I; Mashamaite S; Majuba P; Xulu T; Long L; Onoya D
BMC Public Health; 2019 Nov; 19(1):1471. PubMed ID: 31699063
[TBL] [Abstract][Full Text] [Related]
31. CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study.
Grimsrud A; Cornell M; Schomaker M; Fox MP; Orrell C; Prozesky H; Stinson K; Tanser F; Egger M; Myer L;
J Epidemiol Community Health; 2016 Jun; 70(6):549-55. PubMed ID: 26700300
[TBL] [Abstract][Full Text] [Related]
32. Low risk of attrition among adults on antiretroviral therapy in the Rwandan national program: a retrospective cohort analysis of 6, 12, and 18 month outcomes.
Nuwagaba-Biribonwoha H; Jakubowski A; Mugisha V; Basinga P; Asiimwe A; Nash D; Elul B
BMC Public Health; 2014 Aug; 14():889. PubMed ID: 25168699
[TBL] [Abstract][Full Text] [Related]
33. Retention of HIV infected pregnant and breastfeeding women on option B+ in Gomba District, Uganda: a retrospective cohort study.
Kiwanuka G; Kiwanuka N; Muneza F; Nabirye J; Oporia F; Odikro MA; Castelnuovo B; Wanyenze RK
BMC Infect Dis; 2018 Oct; 18(1):533. PubMed ID: 30355356
[TBL] [Abstract][Full Text] [Related]
34. Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia.
Koole O; Tsui S; Wabwire-Mangen F; Kwesigabo G; Menten J; Mulenga M; Auld A; Agolory S; Mukadi YD; Colebunders R; Bangsberg DR; van Praag E; Torpey K; Williams S; Kaplan J; Zee A; Denison J
Trop Med Int Health; 2014 Dec; 19(12):1397-410. PubMed ID: 25227621
[TBL] [Abstract][Full Text] [Related]
35. Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe's national antiretroviral therapy programme between 2012 and 2015.
Makurumidze R; Mutasa-Apollo T; Decroo T; Choto RC; Takarinda KC; Dzangare J; Lynen L; Van Damme W; Hakim J; Magure T; Mugurungi O; Rusakaniko S
PLoS One; 2020; 15(1):e0222309. PubMed ID: 31910445
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal engagement trajectories and risk of death among new ART starters in Zambia: A group-based multi-trajectory analysis.
Mody A; Eshun-Wilson I; Sikombe K; Schwartz SR; Beres LK; Simbeza S; Mukamba N; Somwe P; Bolton-Moore C; Padian N; Holmes CB; Sikazwe I; Geng EH
PLoS Med; 2019 Oct; 16(10):e1002959. PubMed ID: 31661487
[TBL] [Abstract][Full Text] [Related]
37. Patient-level benefits associated with decentralization of antiretroviral therapy services to primary health facilities in Malawi and Uganda.
Abongomera G; Chiwaula L; Revill P; Mabugu T; Tumwesige E; Nkhata M; Cataldo F; van Oosterhout J; Colebunders R; Chan AK; Kityo C; Gilks C; Hakim J; Seeley J; Gibb DM; Ford D
Int Health; 2018 Jan; 10(1):8-19. PubMed ID: 29329396
[TBL] [Abstract][Full Text] [Related]
38. Two-year death and loss to follow-up outcomes by source of referral to HIV care for HIV-infected patients initiating antiretroviral therapy in rural Mozambique.
Blevins M; José E; Bilhete FR; Vaz LM; Shepherd BE; Audet CM; Vermund SH; Moon TD
AIDS Res Hum Retroviruses; 2015 Feb; 31(2):198-207. PubMed ID: 25381732
[TBL] [Abstract][Full Text] [Related]
39. Impact of early initiation versus national standard of care of antiretroviral therapy in Swaziland's public sector health system: study protocol for a stepped-wedge randomized trial.
Walsh FJ; Bärnighausen T; Delva W; Fleming Y; Khumalo G; Lejeune CL; Mazibuko S; Mlambo CK; Reis R; Spiegelman D; Zwane M; Okello V
Trials; 2017 Aug; 18(1):383. PubMed ID: 28821264
[TBL] [Abstract][Full Text] [Related]
40. A Decade of Antiretroviral Therapy Scale-up in Mozambique: Evaluation of Outcome Trends and New Models of Service Delivery Among More Than 300,000 Patients Enrolled During 2004-2013.
Auld AF; Shiraishi RW; Couto A; Mbofana F; Colborn K; Alfredo C; Ellerbrock TV; Xavier C; Jobarteh K
J Acquir Immune Defic Syndr; 2016 Oct; 73(2):e11-22. PubMed ID: 27454248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
